Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
Public ClinicalTrials.gov record NCT02839200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center, Double-blind, Randomized, Placebo-controlled, Active-reference, Parallel-group, Polysomnography Dose-response Study to Assess the Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the dose response of ACT-541468 on the change of WASO from baseline to Days 1 and 2, assessed by PSG.
Study identification
- NCT ID
- NCT02839200
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 360 participants
Conditions and interventions
Conditions
Interventions
- ACT-541468 5 mg Drug
- ACT-541468 10 mg Drug
- ACT-541468 25 mg Drug
- Zolpidem Drug
- Placebo 1 Drug
- Placebo 2 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2016 (Actual)
- Primary completion
- Apr 12, 2017 (Actual)
- Completion
- Jun 20, 2017 (Actual)
- Last update posted
- Apr 13, 2020
2016 – 2017
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site | Santa Monica | California | 90404 | — |
| Investigator Site | Upland | California | 91786 | — |
| Investigator Site | Brandon | Florida | 33511 | — |
| Investigator Site | Clearwater | Florida | 33765 | — |
| Investigator Site | Coral Gables | Florida | 33134 | — |
| Investigator Site | DeLand | Florida | 32720 | — |
| Investigator Site | Hollywood | Florida | 33024 | — |
| Investigator Site | Miami | Florida | 33143 | — |
| Investigator Site | Atlanta | Georgia | 30342 | — |
| Investigator Site | Chicago | Illinois | 60634 | — |
| Investigator Site | Indianapolis | Indiana | 46250 | — |
| Investigator Site | Novi | Michigan | 48377 | — |
| Investigator Site | Las Vegas | Nevada | 89104 | — |
| Investigator Site | New York | New York | 10019 | — |
| Investigator Site | Cincinnati | Ohio | 45255 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02839200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02839200 live on ClinicalTrials.gov.